Ultragenyx Pharmaceutical Inc. (RARE)
USD 39.3
(0.85%)
USD 39.3
(0.85%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -516.45 Million USD | 19.17% |
| 2022 | -640.51 Million USD | -67.61% |
| 2021 | -410.32 Million USD | -18.3% |
| 2020 | -139.8 Million USD | 21.68% |
| 2019 | -389.77 Million USD | 23.99% |
| 2018 | -177.55 Million USD | -64.68% |
| 2017 | -312.51 Million USD | -32.63% |
| 2016 | -244.58 Million USD | -69.46% |
| 2015 | -146.35 Million USD | -157.77% |
| 2014 | -56.09 Million USD | -63.98% |
| 2013 | -34.62 Million USD | -116.13% |
| 2012 | -16.02 Million USD | -144.78% |
| 2011 | -6.54 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -107.49 Million USD | 27.22% |
| 2024 Q1 | -156.5 Million USD | -43.6% |
| 2023 FY | - USD | 19.17% |
| 2023 Q3 | -139.91 Million USD | -0.93% |
| 2023 Q1 | -147.5 Million USD | -5.93% |
| 2023 Q2 | -138.62 Million USD | 6.02% |
| 2023 Q4 | -103.23 Million USD | 26.22% |
| 2022 Q3 | -222.68 Million USD | -62.38% |
| 2022 Q4 | -139.25 Million USD | 37.47% |
| 2022 FY | - USD | -67.61% |
| 2022 Q1 | -131.76 Million USD | -28.5% |
| 2022 Q2 | -137.14 Million USD | -4.08% |
| 2021 Q4 | -102.53 Million USD | -14.14% |
| 2021 FY | - USD | -18.3% |
| 2021 Q1 | -106.72 Million USD | -12.58% |
| 2021 Q2 | -82.4 Million USD | 22.79% |
| 2021 Q3 | -89.83 Million USD | -9.02% |
| 2020 Q2 | -57.85 Million USD | 51.05% |
| 2020 Q4 | -94.79 Million USD | -109.09% |
| 2020 Q1 | -118.2 Million USD | -29.14% |
| 2020 FY | - USD | 21.68% |
| 2020 Q3 | -45.33 Million USD | 21.64% |
| 2019 Q2 | -122.3 Million USD | -23.27% |
| 2019 FY | - USD | 23.99% |
| 2019 Q1 | -99.21 Million USD | -9.82% |
| 2019 Q4 | -91.52 Million USD | 23.85% |
| 2019 Q3 | -120.19 Million USD | 1.72% |
| 2018 Q3 | -89.64 Million USD | 33.7% |
| 2018 FY | - USD | -64.68% |
| 2018 Q1 | -226.48 Million USD | -133.89% |
| 2018 Q2 | -135.22 Million USD | 40.3% |
| 2018 Q4 | -90.34 Million USD | -0.77% |
| 2017 FY | - USD | -32.63% |
| 2017 Q1 | -68.79 Million USD | 2.49% |
| 2017 Q2 | -77.38 Million USD | -12.49% |
| 2017 Q3 | -82.61 Million USD | -6.76% |
| 2017 Q4 | -96.83 Million USD | -17.21% |
| 2016 Q1 | -53.07 Million USD | 4.67% |
| 2016 Q4 | -70.54 Million USD | -7.25% |
| 2016 Q3 | -65.78 Million USD | -14.68% |
| 2016 Q2 | -57.36 Million USD | -8.07% |
| 2016 FY | - USD | -69.46% |
| 2015 Q3 | -39.93 Million USD | -33.65% |
| 2015 Q2 | -29.88 Million USD | -40.28% |
| 2015 Q1 | -21.3 Million USD | -25.72% |
| 2015 FY | - USD | -157.77% |
| 2015 Q4 | -55.67 Million USD | -39.42% |
| 2014 Q1 | -10.22 Million USD | 8.77% |
| 2014 Q4 | -16.94 Million USD | -8.32% |
| 2014 Q3 | -15.64 Million USD | -15.86% |
| 2014 Q2 | -13.5 Million USD | -32.07% |
| 2014 FY | - USD | -63.98% |
| 2013 Q1 | -6.62 Million USD | -36.9% |
| 2013 Q3 | -7.65 Million USD | 5.99% |
| 2013 Q4 | -11.2 Million USD | -46.36% |
| 2013 FY | - USD | -116.13% |
| 2013 Q2 | -8.14 Million USD | -22.97% |
| 2012 Q4 | -4.83 Million USD | 0.0% |
| 2012 FY | - USD | -144.78% |
| 2011 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -4757.086% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -18669.362% |
| XOMA Corporation | -39.36 Million USD | -1212.062% |
| Mesoblast Limited | -61.33 Million USD | -742.077% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -2075.917% |
| Aptorum Group Limited | -9.59 Million USD | -5280.291% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4470.243% |
| HilleVax, Inc. | -132.46 Million USD | -289.877% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -118.261% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -1062.224% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1511.803% |
| Dyadic International, Inc. | -8.22 Million USD | -6175.46% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -5020.504% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -295.99% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -177375.601% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1665.172% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -648.473% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -172.862% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -321.574% |
| IGM Biosciences, Inc. | -253.35 Million USD | -103.844% |
| Opthea Limited | -200.01 Million USD | -158.203% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -808.53% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -921.225% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -352.676% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 607.686% |
| NextCure, Inc. | -59.03 Million USD | -774.768% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -2493.631% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -779.622% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -2297.762% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -2037.11% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -228.544% |
| Senti Biosciences, Inc. | -61.33 Million USD | -742.008% |
| Apollomics, Inc. | -171.74 Million USD | -200.706% |
| PureTech Health plc | -11.62 Million USD | -4341.851% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 23207.562% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -590.309% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -260.65% |
| ChromaDex Corporation | -3.89 Million USD | -13162.815% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 120474.605% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -7419.715% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -490.726% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 209007.999% |
| Gritstone bio, Inc. | -126.86 Million USD | -307.096% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -22856.378% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -199.865% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -212.206% |
| Fortress Biotech, Inc. | -133.64 Million USD | -286.443% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -890.362% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1547.171% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -129.281% |
| Celcuity Inc. | -58.3 Million USD | -785.705% |
| ContextLogic Inc. | -324 Million USD | -59.399% |
| GH Research PLC | -41.15 Million USD | -1154.961% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -567.745% |
| Cassava Sciences, Inc. | -95.68 Million USD | -439.733% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1931.524% |
| ImmuCell Corporation | -2.5 Million USD | -20524.526% |
| Amarin Corporation plc | -50.9 Million USD | -914.614% |
| TG Therapeutics, Inc. | 26.1 Million USD | 2078.751% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -382.203% |
| Acelyrin, Inc. | -381.52 Million USD | -35.365% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10678.622% |
| Seer, Inc. | -97.88 Million USD | -427.613% |
| Novavax, Inc. | -487.39 Million USD | -5.963% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -224.714% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 135.632% |
| AnaptysBio, Inc. | -143.16 Million USD | -260.743% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1724.217% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -554.775% |
| AbCellera Biologics Inc. | -192.15 Million USD | -168.765% |
| CorMedix Inc. | -48.88 Million USD | -956.423% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -119.708% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -4279.597% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 111.097% |
| Aptose Biosciences Inc. | -52.26 Million USD | -888.088% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -379.337% |
| Soligenix, Inc. | -7.85 Million USD | -6476.644% |
| Century Therapeutics, Inc. | -121.2 Million USD | -326.089% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -193.988% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2773.427% |
| Kura Oncology, Inc. | -164.95 Million USD | -213.088% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -310.386% |
| Ardelyx, Inc. | -55.35 Million USD | -833.002% |
| Ainos, Inc. | -8.77 Million USD | -5786.792% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -544.778% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -53824.295% |
| Prothena Corporation plc | -190.1 Million USD | -171.663% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -11885.472% |
| Autolus Therapeutics plc | -156.77 Million USD | -229.434% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -510.055% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -302.857% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -2490.82% |
| Celularity Inc. | -183.94 Million USD | -180.764% |
| Rallybio Corporation | -72.37 Million USD | -613.6% |
| GRI Bio, Inc. | -10.89 Million USD | -4638.98% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -11336.816% |
| Omeros Corporation | -163.61 Million USD | -215.662% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -397.586% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1254.341% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3268.711% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -3180.481% |
| Humacyte, Inc. | -96.45 Million USD | -435.419% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -94.158% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -166.297% |
| Immunocore Holdings plc | -59.64 Million USD | -765.822% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -2565.982% |
| Verastem, Inc. | -83.16 Million USD | -520.992% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -226.399% |
| Histogen Inc. | -10.5 Million USD | -4817.205% |
| Surrozen, Inc. | -41.13 Million USD | -1155.632% |
| Blueprint Medicines Corporation | -474.61 Million USD | -8.816% |
| Organovo Holdings, Inc. | -14.8 Million USD | -3388.14% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 16104060.087% |
| IO Biotech, Inc. | -91.22 Million USD | -466.113% |
| MEI Pharma, Inc. | 26.38 Million USD | 2057.748% |
| GT Biopharma, Inc. | 5.97 Million USD | 8737.799% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -210.993% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -948.457% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -605.211% |
| Summit Therapeutics Inc. | 1 Million USD | 51693.806% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1571.156% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -311.527% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -3330.439% |
| Turnstone Biologics Corp. | -56.23 Million USD | -818.402% |
| Pulmatrix, Inc. | -12.64 Million USD | -3983.932% |
| Synaptogenix, Inc. | -8.3 Million USD | -6116.715% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -3266.934% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -719.157% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -483.782% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | -2.003% |
| Cytokinetics, Incorporated | -456.68 Million USD | -13.088% |
| Exelixis, Inc. | 196.6 Million USD | 362.69% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -265.22% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | -4.29% |
| Evogene Ltd. | -23.2 Million USD | -2125.711% |
| Replimune Group, Inc. | -230.19 Million USD | -124.352% |
| PDS Biotechnology Corporation | -40.08 Million USD | -1188.398% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -337123.227% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -694.728% |
| ESSA Pharma Inc. | -26.45 Million USD | -1852.175% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -12811.524% |
| BioLineRx Ltd. | -57.06 Million USD | -805.091% |
| Avid Bioservices, Inc. | -11.48 Million USD | -4398.336% |
| Insmed Incorporated | -654.73 Million USD | 21.121% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1491.391% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -87.459% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1580.072% |
| MediWound Ltd. | -4.89 Million USD | -10454.956% |
| MiMedx Group, Inc. | 40.51 Million USD | 1374.66% |
| OmniAb, Inc. | -49.73 Million USD | -938.495% |
| Alector, Inc. | -142.89 Million USD | -261.43% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -504.506% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -56.34% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1882.092% |
| Zai Lab Limited | -366.57 Million USD | -40.887% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -77.697% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -124.602% |
| Aura Biosciences, Inc. | -83.69 Million USD | -517.059% |
| Immunic, Inc. | -99.11 Million USD | -421.081% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -121.202% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -292.234% |
| Veracyte, Inc. | -49.4 Million USD | -945.263% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -7211.142% |
| FibroGen, Inc. | -261.4 Million USD | -97.569% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4535.616% |
| Allakos Inc. | -189.91 Million USD | -171.94% |
| scPharmaceuticals Inc. | -46.06 Million USD | -1021.239% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -376.03% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 576.768% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -7276.515% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4278.341% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2659.297% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1394.695% |
| Precigen, Inc. | -89.22 Million USD | -478.816% |
| Fortrea Holdings Inc. | 167.3 Million USD | 408.699% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -284.61% |
| Incyte Corporation | 919.42 Million USD | 156.171% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -5123.616% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -338.975% |
| XBiotech Inc. | -35.76 Million USD | -1343.98% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -516.183% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -694.728% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -2041.905% |
| CRISPR Therapeutics AG | -202.7 Million USD | -154.786% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -247.474% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -3682.714% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -691.5% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -394.427% |
| Agenus Inc. | -145.92 Million USD | -253.92% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -4081.806% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1911.74% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -1163.743% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -821.894% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -7983.962% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -343.937% |
| UroGen Pharma Ltd. | -63.83 Million USD | -709.096% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -2229.564% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -660.442% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -9246.657% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1923.802% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1933.924% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -359.871% |
| Chimerix, Inc. | -92.97 Million USD | -455.482% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -528.037% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -800.123% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -36103.134% |
| Pluri Inc. | -20.22 Million USD | -2453.543% |
| Cue Biopharma, Inc. | -46.05 Million USD | -1021.458% |
| MeiraGTx Holdings plc | -57.05 Million USD | -805.234% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -3516.699% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -6093.976% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -2019.655% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2799.85% |
| CalciMedica, Inc. | -34.18 Million USD | -1410.585% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -206.59% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -104.625% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1466.626% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4278.341% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -410.254% |
| Nutriband Inc. | -5.12 Million USD | -9983.493% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -1093.506% |
| Vor Biopharma Inc. | -114.37 Million USD | -351.56% |
| Roivant Sciences Ltd. | -996.51 Million USD | 48.174% |
| ProKidney Corp. | -147.66 Million USD | -249.738% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -700.27% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1582.177% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 8.668% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -7108.011% |
| Bicycle Therapeutics plc | -183.4 Million USD | -181.6% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -362.118% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -255570.297% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -19.943% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1322.307% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -549.489% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -535.143% |
| MediciNova, Inc. | -9.87 Million USD | -5127.283% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -310.076% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -33650.729% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1836.55% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -471.678% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -129.544% |
| Biomea Fusion, Inc. | -124.62 Million USD | -314.423% |
| RenovoRx, Inc. | -11.39 Million USD | -4434.276% |
| Erasca, Inc. | -121.31 Million USD | -325.731% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -171.334% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1620.08% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -382.136% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -2159.698% |
| bluebird bio, Inc. | -167.16 Million USD | -208.956% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -148.491% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -2168.931% |
| Imunon, Inc. | -19.87 Million USD | -2498.082% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 266.446% |
| BioAtla, Inc. | -122.24 Million USD | -322.488% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -71.983% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -1146.059% |
| DBV Technologies S.A. | -85.98 Million USD | -500.654% |
| Fortress Biotech, Inc. | -133.64 Million USD | -286.443% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -121.182% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -420.336% |
| aTyr Pharma, Inc. | -52.17 Million USD | -889.793% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -120.175% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -6321.72% |
| Galecto, Inc. | -37.51 Million USD | -1276.513% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2973.765% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 273781.812% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 214.273% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -215.944% |
| Entera Bio Ltd. | -8.8 Million USD | -5766.129% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -58.302% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1446.918% |
| Xencor, Inc. | -125.87 Million USD | -310.294% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -908.325% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -990.348% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -2462.079% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -4619.923% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -7983.962% |
| Portage Biotech Inc. | -18.19 Million USD | -2737.815% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -33650.729% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -393.817% |
| OncoCyte Corporation | -23.12 Million USD | -2133.508% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4407.823% |
| Purple Biotech Ltd. | -22.22 Million USD | -2223.753% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -7957.005% |
| Onconetix, Inc. | -36.7 Million USD | -1306.974% |
| MacroGenics, Inc. | 2.01 Million USD | 25705.057% |
| Tharimmune, Inc. | -9.3 Million USD | -5451.723% |
| Genprex, Inc. | -31.06 Million USD | -1562.732% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -514.936% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -175.404% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -5081.12% |
| Prime Medicine, Inc. | -193.75 Million USD | -166.545% |
| Aditxt, Inc. | -25.45 Million USD | -1928.654% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -67498.691% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 342340.1% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3279833.087% |
| Savara Inc. | -59.13 Million USD | -773.377% |
| Curis, Inc. | -45.13 Million USD | -1044.141% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -3299.704% |
| Adagene Inc. | -14.95 Million USD | -3354.36% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1831.825% |
| BeiGene, Ltd. | -1.12 Billion USD | 54.077% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -149.865% |
| GlycoMimetics, Inc. | -39.12 Million USD | -1220.112% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 172.494% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -11379.929% |
| SciSparc Ltd. | -5.28 Million USD | -9677.622% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -11379.929% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1112.077% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -542348.114% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -2280.913% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -9044.016% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -127.079% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -762.885% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -99.988% |
| ADMA Biologics, Inc. | 5.12 Million USD | 10186.992% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2941.364% |
| Clene Inc. | -43.24 Million USD | -1094.362% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -271.459% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -150.876% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -965.359% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -72.401% |
| Adicet Bio, Inc. | -136.53 Million USD | -278.258% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 2290.871% |
| Absci Corporation | -95.45 Million USD | -441.033% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6964.939% |
| Quantum-Si incorporated | -91.8 Million USD | -462.562% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 508.409% |
| Surrozen, Inc. | -41.13 Million USD | -1155.632% |
| Generation Bio Co. | -133.3 Million USD | -287.437% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -522.009% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -358.932% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -500.367% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -627.154% |
| Invivyd, Inc. | -196.61 Million USD | -162.673% |
| Cingulate Inc. | -22.95 Million USD | -2150.145% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -38.033% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -5468.358% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -6178.03% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 2001.944% |
| Jaguar Health, Inc. | -33.13 Million USD | -1458.824% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4921.429% |
| 2seventy bio, Inc. | -206.41 Million USD | -150.198% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -2139.804% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -405.01% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -661.428% |
| Capricor Therapeutics, Inc. | -23 Million USD | -2144.576% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1306.107% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 10617.865% |
| Kronos Bio, Inc. | -121.83 Million USD | -323.914% |
| Innoviva, Inc. | 248.96 Million USD | 307.445% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -594.7% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -160789.097% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -226.036% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 24.529% |
| Evaxion Biotech A/S | -21.4 Million USD | -2312.998% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -677.617% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -137.266% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -548.877% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -6822.048% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1285.227% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -784.763% |
| Clearmind Medicine Inc. | -8.71 Million USD | -5828.986% |
| AlloVir, Inc. | -190.14 Million USD | -171.609% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -370.582% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 694.911% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -21053.889% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -412.218% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -239.377% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 97728.355% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -133.152% |
| ImmunityBio, Inc. | -436.18 Million USD | -18.403% |
| Korro Bio, Inc. | -80.9 Million USD | -538.354% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -322.966% |
| Kineta, Inc. | -15.71 Million USD | -3186.585% |
| Lantern Pharma Inc. | -15.78 Million USD | -3171.452% |
| BioVie Inc. | -31.95 Million USD | -1516.434% |
| Codexis, Inc. | -49.28 Million USD | -947.935% |
| Celularity Inc. | -183.94 Million USD | -180.764% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| Virax Biolabs Group Limited | -6.6 Million USD | -7714.234% |
| Kodiak Sciences Inc. | -259.02 Million USD | -99.385% |
| Cibus, Inc. | -314.58 Million USD | -64.17% |
| Annexon, Inc. | -141.57 Million USD | -264.792% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -704.496% |
| Moderna, Inc. | -3.28 Billion USD | 84.269% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -124.535% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -358.667% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1747.448% |
| Immix Biopharma, Inc. | -16.13 Million USD | -3100.703% |
| Eyenovia, Inc. | -24.1 Million USD | -2042.426% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1253.211% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -276.729% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -778.473% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -159299.383% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -599.764% |
| Alkermes plc | 495.04 Million USD | 204.324% |
| Arcellx, Inc. | -64.14 Million USD | -705.135% |
| Moolec Science SA | -52.07 Million USD | -891.74% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -1047.319% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -1177.814% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -318.263% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1572.346% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -331.843% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -965.447% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5438.824% |
| Humacyte, Inc. | -96.45 Million USD | -435.419% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -900.763% |
| Geron Corporation | -174.78 Million USD | -195.485% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -730.352% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 12845.656% |
| Royalty Pharma plc | 1.88 Billion USD | 127.365% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -2390.044% |
| Notable Labs, Ltd. | -14.4 Million USD | -3486.486% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -210.967% |
| Structure Therapeutics Inc. | -102.45 Million USD | -404.059% |
| IN8bio, Inc. | -28.5 Million USD | -1711.865% |
| 89bio, Inc. | -134.46 Million USD | -284.086% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -2574.819% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -406.268% |
| Acasti Pharma Inc. | -11.3 Million USD | -4469.985% |
| Genelux Corporation | -24.16 Million USD | -2037.198% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1427.97% |
| Liquidia Corporation | -70.05 Million USD | -637.254% |
| Mustang Bio, Inc. | -48.06 Million USD | -974.536% |
| Immunovant, Inc. | -269.97 Million USD | -91.295% |
| Vericel Corporation | 2.86 Million USD | 18132.612% |
| Quantum-Si incorporated | -91.8 Million USD | -462.562% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -627.543% |
| XOMA Corporation | -39.36 Million USD | -1212.062% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -665.718% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -2220.803% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3268.711% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1392.383% |
| Vaxcyte, Inc. | -464.88 Million USD | -11.093% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -145.331% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6964.939% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3152.229% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1694.739% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1683.151% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -206.566% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1294.691% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1730.164% |
| PepGen Inc. | -83.58 Million USD | -517.901% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1650.454% |
| United Therapeutics Corporation | 1.38 Billion USD | 137.241% |
| Solid Biosciences Inc. | -93.43 Million USD | -452.747% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -10723.189% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -159299.383% |
| Immuneering Corporation | -58.06 Million USD | -789.505% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 16104060.087% |
| Silo Pharma, Inc. | -3.62 Million USD | -14142.237% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -8343.556% |
| Belite Bio, Inc | -31.52 Million USD | -1538.028% |
| Pharming Group N.V. | 9.87 Million USD | 5328.855% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -2041.905% |
| Bionomics Limited | -9.83 Million USD | -5150.12% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -557.962% |
| uniQure N.V. | -253.1 Million USD | -104.051% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -2461.903% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1836.55% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -298.794% |
| Altimmune, Inc. | -87.93 Million USD | -487.313% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -6315.201% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1392.383% |
| Peak Bio, Inc. | -1356.23 USD | -38080019.154% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4535.616% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -3147.934% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2196.372% |
| Zura Bio Limited | -60.56 Million USD | -752.755% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -460.881% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -4008114.273% |
| Compugen Ltd. | -12.51 Million USD | -4026.35% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -11993.97% |
| argenx SE | -216.02 Million USD | -139.074% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -962.706% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2155.553% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -113.144% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1709.389% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -35.92% |
| PolyPid Ltd. | -20.26 Million USD | -2448.754% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -3207.846% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -3968.81% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1490.215% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -972.06% |
| Instil Bio, Inc. | -146.12 Million USD | -253.44% |
| Elevation Oncology, Inc. | -41.46 Million USD | -1145.458% |
| Immunome, Inc. | -28.27 Million USD | -1726.798% |
| Verona Pharma plc | -52.46 Million USD | -884.33% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2913.153% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -444.944% |
| Shattuck Labs, Inc. | -87.61 Million USD | -489.458% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -322.478% |
| Design Therapeutics, Inc. | -66.32 Million USD | -678.672% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -537.7% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1268.09% |
| Achilles Therapeutics plc | -70.44 Million USD | -633.162% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -921.67% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -691.173% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -854.453% |
| Beam Therapeutics Inc. | -156.47 Million USD | -230.059% |
| Moolec Science SA | -52.07 Million USD | -891.74% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -809.987% |
| AEON Biopharma, Inc. | -48.36 Million USD | -967.914% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -690.108% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -530.345% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -20.827% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -390.94% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -296.081% |
| Athira Pharma, Inc. | -116.7 Million USD | -342.537% |
| HCW Biologics Inc. | -23.57 Million USD | -2090.587% |
| XOMA Corporation | -39.36 Million USD | -1212.062% |
| NeurAxis, Inc. | -6.66 Million USD | -7649.334% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1312.234% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -444.944% |
| 180 Life Sciences Corp. | -22.13 Million USD | -2233.303% |
| Nektar Therapeutics | -243.1 Million USD | -112.439% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1709.389% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 8959.703% |
| Arvinas, Inc. | -394.8 Million USD | -30.814% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -21053.889% |
| Palisade Bio, Inc. | -12.28 Million USD | -4105.309% |
| Nutriband Inc. | -5.12 Million USD | -9983.493% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 273781.812% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -831.689% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -1038.166% |
| Merus N.V. | -149.2 Million USD | -246.133% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -452.416% |
| Neurogene Inc. | -52.28 Million USD | -887.748% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -278.382% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -6051.191% |
| CervoMed Inc. | -2.17 Million USD | -23679.188% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -455.219% |
| Sesen Bio, Inc. | -50.84 Million USD | -915.842% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1552.124% |
| Rezolute, Inc. | -68.42 Million USD | -654.796% |
| Clene Inc. | -43.24 Million USD | -1094.362% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3248.772% |
| BeyondSpring Inc. | -21.54 Million USD | -2297.651% |
| Synlogic, Inc. | -55.16 Million USD | -836.267% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -4174.22% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -4752.979% |
| Peak Bio, Inc. | -1356.23 USD | -38080019.154% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1490.802% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2984.573% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -336.11% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -51.299% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -11111.584% |
| MannKind Corporation | 15.12 Million USD | 3513.669% |
| Ikena Oncology, Inc. | -74.39 Million USD | -594.187% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -4001.12% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2640.729% |
| Gossamer Bio, Inc. | -172.15 Million USD | -199.999% |
| CohBar, Inc. | -12.06 Million USD | -4180.327% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1924.595% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1620.08% |
| Legend Biotech Corporation | -477.87 Million USD | -8.073% |
| Mural Oncology plc | -192.72 Million USD | -167.982% |
| Disc Medicine, Inc. | -91.02 Million USD | -467.376% |
| Champions Oncology, Inc. | -5.05 Million USD | -10118.718% |
| REGENXBIO Inc. | -239.46 Million USD | -115.671% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4718.483% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -826.275% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1232.156% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -357.825% |
| Vaxart, Inc. | -74.72 Million USD | -591.158% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1366.853% |
| Cellectis S.A. | -98.09 Million USD | -426.484% |
| Longeveron Inc. | -20.06 Million USD | -2474.546% |
| Repare Therapeutics Inc. | -114.27 Million USD | -351.948% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -17.591% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -590.336% |
| Revolution Medicines, Inc. | -430.58 Million USD | -19.943% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -8112.021% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1577.398% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -592.39% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 10633.429% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -4610.023% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 111.215% |
| Denali Therapeutics Inc. | -179.97 Million USD | -186.962% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -542348.114% |
| Veru Inc. | -89.97 Million USD | -473.994% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1821.475% |
| Cingulate Inc. | -22.95 Million USD | -2150.145% |
| Passage Bio, Inc. | -98.34 Million USD | -425.167% |
| Context Therapeutics Inc. | -25.06 Million USD | -1960.823% |
| Exicure, Inc. | -15.53 Million USD | -3223.599% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -150.628% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1296.728% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -8561.563% |
| Nuvalent, Inc. | -149.49 Million USD | -245.473% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -6250.561% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -501.269% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1611.359% |
| OmniAb, Inc. | -49.73 Million USD | -938.495% |
| Anew Medical, Inc. | -1.3 Million USD | -39601.577% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -4077.079% |
| Lipocine Inc. | -16.32 Million USD | -3064.03% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -674.642% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -595.065% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1254.341% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -1223.766% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -2228.152% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 5.25% |
| Ocugen, Inc. | -64.82 Million USD | -696.665% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -457.906% |
| Q32 Bio Inc. | -86.5 Million USD | -497.043% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2951.066% |
| Alumis Inc. Common Stock | -156.89 Million USD | -229.182% |
| Equillium, Inc. | -12.13 Million USD | -4154.853% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -783.25% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -6434.622% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2638.215% |
| Dominari Holdings Inc. | -22.44 Million USD | -2201.488% |
| Edesa Biotech, Inc. | -8.19 Million USD | -6205.8% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1932.323% |
| Bio-Techne Corporation | 326.66 Million USD | 258.1% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -34.191% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 338.669% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -293.915% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1279.749% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -241.794% |
| Nkarta, Inc. | -120.48 Million USD | -328.66% |
| BioCardia, Inc. | -11.56 Million USD | -4367.595% |
| Iterum Therapeutics plc | -34.58 Million USD | -1393.505% |